drugset
drugset / Trial / NCT01574365

A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

NCT01574365 ↗

Phase 2 Terminated 53 enrolled Kyowa Kirin, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

A Phase 2 study of RTA 402 in Chronic kidney disease (CKD) patients with type 2 diabetes mellitus.

Timeline

Start
2012-02
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bardoxolone methyl Small molecule — —

Indications

chronic kidney disease type 2 diabetes mellitus